Capital World Investors Teva Pharmaceutical Industries LTD Transaction History

Capital World Investors

$597 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$7.2 - $9.47 $364 Million - $478 Million	-50,519,746 Reduced 99.76%	119,417 $899,000
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $628,471 - $854,751	75,176 Added 0.15%	50,639,163 $448 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $89.3 Million - $107 Million	11,234,222 Added 28.56%	50,563,987 $461 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $270 Million - $470 Million	39,329,765 New	39,329,765 $317 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $48.9 Million - $63 Million	-6,185,616 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $362 Million - $439 Million	-43,150,734 Reduced 87.46%	6,185,616 $60.2 Million
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $36.5 Million - $42.6 Million	-3,684,423 Reduced 6.95%	49,336,350 $488 Million
Q1 2021 May 14, 2021	BUY	$10.34 - $12.81 $1.46 Million - $1.81 Million	141,396 Added 0.27%	53,020,773 $612 Million
Q4 2020 Feb 12, 2021	BUY	$8.61 - $11.04 $627,470 - $804,562	72,877 Added 0.14%	52,879,377 $510 Million
Q3 2020 Nov 13, 2020	BUY	$8.57 - $12.69 $80.3 Million - $119 Million	9,375,273 Added 21.59%	52,806,500 $476 Million
Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $84 Million - $136 Million	10,344,401 Added 31.26%	43,431,227 $536 Million
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $17.6 Million - $35.3 Million	-2,626,236 Reduced 7.35%	33,086,826 $297 Million
Q4 2019 Feb 18, 2020	BUY	$6.53 - $10.72 $13.5 Million - $22.1 Million	2,065,840 Added 6.14%	35,713,062 $350 Million
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $36.7 Million - $57.2 Million	-5,958,254 Reduced 15.04%	33,647,222 $231 Million
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $57 Million - $110 Million	-7,023,189 Reduced 15.06%	39,605,476 $366 Million
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $23.5 Million - $30.2 Million	-1,509,570 Reduced 3.14%	46,628,665 $731 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $9.94 Million - $16.2 Million	681,516 Added 1.44%	48,138,235 $742 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $102 Million - $124 Million	4,841,681 Added 11.36%	47,456,719 $1.02 Billion
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $69 Million - $102 Million	4,114,223 Added 10.69%	42,615,038 $1.04 Billion
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $565 Million - $748 Million	33,901,815 Added 737.16%	38,500,815 $658 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $44,920 - $76,400	4,000 Added 0.09%	4,599,000 $87.2 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $70.8 Million - $148 Million	4,595,000	4,595,000 $80.9 Million

Others Institutions Holding TEVA

# of Institutions

603

Shares Held

567M

Call Options Held

25.2M

Put Options Held

5.08M

Black Rock Inc. New York, NY

43M
Shares

$768 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.3M
Shares

$649 Million
41.14% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

32.3M
Shares

$578 Million
5.5% of portfolio
Migdal Insurance & Financial Holdings Ltd.

29.1M
Shares

$520 Million
7.9% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$515 Million
3.23% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account